FRONTEO announces automatic classification / examination AI software "Mekiki" ver.1.0 of medical information text

2021.08.03 Press release

--To the press -

FRONTEO announces automatic classification / examination AI software "Mekiki" ver.1.0 of medical information text

FRONTEO Inc.
Masahiro Morimoto, President and CEO
2-12-23 Konan, Minato-ku, Tokyo
(Code number: 2158 TSE Mothers)

 FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereafter FRONTEO) is pleased to announce the automatic classification AI software "Mekiki (trademark application)" that uses artificial intelligence (AI) to sort medical expertise. Medium, reading: Mekiki) ”is now available.

 

 

 In addition to handling medical specialty information based on strict standards in operations such as clinical development, regulatory application, and quality control, pharmaceutical companies provide supervision and guidance on promotional activities in accordance with the "Guidelines for Providing Sales Information for Medical Drugs." We spend a lot of effort and money on document management and document screening.

 

 Mekiki uses FRONTEO's original natural language analysis AI engine "Concept Encoder (trademark: concept encoder, reading: concept encoder)" to handle disease information and product information in the medical field, regardless of the format such as documents and emails, and related information. Supports document management work in the medical field with a system that automatically detects and sorts diverse and advanced medical specialized information such as safety information, competitive product information, sales and public relations related information, etc. according to the purpose. To do.In addition to supporting various file formats, the user company can freely set the sorting classification, and it has a flexible design that can be customized according to the user's purpose.

 

"Mekiki" application screen example. The Concept Encoder analyzes the document and classifies it according to its purpose.
Efficient confirmation is possible by highlighting the words and contents that should be watched.
(System introduction:https://lifescience.fronteo.com/classification/mekiki/

 

 FRONTEO will contribute to the promotion of DX (digital transformation) and operational efficiency in medical institutions and pharmaceutical companies through the development of AI systems that specialize in the needs of the medical field.

 


■ About Concept Encoder

URL:https://lifescience.fronteo.com/technology/conceptencoder/
"Concept Encoder" is a natural language analysis AI (artificial intelligence) developed by FRONTEO specially in the life science field.It was developed in 2018 with the aim of effectively analyzing and utilizing medical data containing a large amount of free-form text data based on evidence. Concept Encoder can be co-analyzed with data other than text, and we are conducting research on co-analysis with numerical data such as gene expression information, vitals, and various test values ​​accumulated in the life science field.Patent registration number: Patent No. 6346367

■ About FRONTEO URL:https://www.fronteo.com/
FRONTEO uses the in-house developed AI engine "KIBIT" and "concept encoder" specializing in natural language processing to extract meaningful and important information from a huge amount of text data to support corporate business. A data analysis company. Since its establishment in August 2003, it has been expanding globally to Japan, the United States, South Korea, and Taiwan, focusing on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support international litigation of companies. Has been deployed.Based on the AI ​​technology cultivated in the legal tech business, we expanded the business field to the life science field, business intelligence field, and economic security from 8, and by using AI to "turn text data into knowledge" , Drug discovery support, dementia diagnosis support, financial / human resources / sales support, etc., contributing to solving various corporate issues. Listed on TSE Mothers on June 2014, 2007. January 6 Obtained a first-class medical device manufacturing and sales license (permit number: 26B2021X1).The capital is 13 thousand yen (as of March 1, 10350).

* FRONTEO, Coroban, conceptencoder, and KIBIT are registered trademarks of FRONTEO in Japan.

<Contact information for the press>

Public Relations Officer, FRONTEO Inc. Segawa

Email: pr_contact@fronteo.com

 

<Inquiries about Life Science AI Business>

FRONTEO Inc. Life Science AI Business Headquarters

https://lifescience.fronteo.com/contact

ja 日本語
Machine Translation by Google. : close x